SABBY MANAGEMENT LLC 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-03 7:24 pm Purchase |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
SABBY MANAGEMENT LLC | 50,459 11.000% |
13,459 (+36.38%) |
Filing |
| 2021-03-03 07:43 am Purchase |
2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX |
SABBY MANAGEMENT LLC | 37,000 11.000% |
37,000 (New Position) |
Filing |